Literature DB >> 15687634

Selection bias in clinical trials.

K D Miller1, Z U Rahman, G W Sledge.   

Abstract

All research is subject to bias that may systematically distort results. Though over 50 types of bias in analytical research have been identified and many classification schemes proposed, this review focuses on the special problem of selection bias in clinical trials. We demonstrate the systematic nature of selection bias in clinical research. We describe the common sources of selection bias in clinical trials including the (inappropriate) use of historical controls, stage migration, inclusion/exclusion criteria, the use of multiple subset analyses, and investigator bias. We then move from the general to the specific, using the recent experience of high dose chemotherapy for breast cancer as an illustrative example. Finally, we suggest means to avoid falling into the many selection bias traps that often confront clinical researchers.

Entities:  

Year:  2001        PMID: 15687634     DOI: 10.3233/bd-2001-14105

Source DB:  PubMed          Journal:  Breast Dis        ISSN: 0888-6008


  8 in total

Review 1.  Clinical pharmacology of melatonin in the treatment of tinnitus: a review.

Authors:  Marco Miroddi; Rocco Bruno; Francesco Galletti; Fabrizio Calapai; Michele Navarra; Sebastiano Gangemi; Gioacchino Calapai
Journal:  Eur J Clin Pharmacol       Date:  2015-01-20       Impact factor: 2.953

2.  Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice.

Authors:  Christian Tanislav; Sonja Milde; Sabine Schwartzkopff; Björn Misselwitz; Nicole Sieweke; Manfred Kaps
Journal:  BMC Res Notes       Date:  2015-06-25

3.  Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients.

Authors:  Christian Tanislav; Ulrike Grittner; Bjoern Misselwitz; Gerhard Jan Jungehuelsing; Christian Enzinger; Bettina von Sarnowski; Jukka Putaala; Manfred Kaps; Peter Kropp; Arndt Rolfs; Turgut Tatlisumak; Franz Fazekas; Edwin Kolodny; Bo Norrving
Journal:  BMC Neurol       Date:  2014-03-07       Impact factor: 2.474

4.  Levetiracetam as a First-line Agent for Neonatal Seizure.

Authors:  Anirban Mandal; Puneet Kaur Sahi
Journal:  J Pediatr Neurosci       Date:  2017 Oct-Dec

5.  Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.

Authors:  Harsha Raj M; Debidas Ghosh; Rita Banerjee; Bharathi P Salimath
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Does influenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias.

Authors:  G K Balasubramani; Sean Saul; Mary Patricia Nowalk; Donald B Middleton; Jill M Ferdinands; Richard K Zimmerman
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

7.  Genetic association of BIN1 and GAB2 in Alzheimer's disease: A meta-analysis and systematic review.

Authors:  Xiaoyan Hao; Aijun Wang; Chong Li; Lufei Shao; Yi Li; Ping Yang
Journal:  Geriatr Gerontol Int       Date:  2020-12-16       Impact factor: 2.730

8.  Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995-2004).

Authors:  Yiqun Chen; Zhenguo Qiu; Anmmd Kamruzzaman; Tom Snodgrass; Andrew Scarfe; Heather E Bryant
Journal:  Support Care Cancer       Date:  2009-05-15       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.